Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2005
06/28/2005US6911206 Fusion proteins comprising carriers that can induce a dual immune response
06/28/2005US6911179 Ozone detecting material and method for detecting ozone
06/28/2005US6911178 Contacting the sample containing an antibody specific for isolated and purified antigenically-active blood group antigen protein or peptide to allow the formation of an immune complex; and detecting the immune complex
06/28/2005US6911152 High-sensitivity method and apparatus for monitoring impurities in water
06/28/2005US6911080 Evaluation process of reactivity of silica glass with silicon melt and vibration at its surface, and silica glass crucible not causing the surface vibration
06/28/2005US6911056 Method for diffracting crystals formed by submicroliter crystallization experiments
06/28/2005US6911007 Method for determining concentration; a dialyser
06/28/2005US6910597 Collection container assembly
06/28/2005US6910393 Powder sampling method and apparatus
06/28/2005US6910371 Extended durability sensing system
06/28/2005CA2402305C Method for spectrometrically measuring isotopic gas and apparatus thereof
06/28/2005CA2367698C Individually addressable micro-electromagnetic unit array chips
06/28/2005CA2232230C Phosphopantetheinyl transferases and uses thereof
06/28/2005CA2140239C Non-invasive testing
06/23/2005WO2005057464A1 A computer based versatile method for identifying protein coding dna sequences useful as drug targets
06/23/2005WO2005057462A1 A method for designing surfaces
06/23/2005WO2005057223A2 Methods for identifying modulators of active kit tyrosine kinase receptor
06/23/2005WO2005057222A2 Use of t-cadherin as a target
06/23/2005WO2005057221A1 Mass spectrometry of arginine-containing peptides
06/23/2005WO2005057220A2 Agents modulating the activity of ccrl2 and methods of using the same
06/23/2005WO2005057219A1 Optical storage medium having an analyte containing polymer film, use thereof
06/23/2005WO2005057218A2 Methods of identifying modulators of apoptosis from parasites and uses thereof
06/23/2005WO2005057217A1 Methods for distinguishing immunoreactive t lymphocytes
06/23/2005WO2005057216A1 Method of reducing the sensitivity of assay devices
06/23/2005WO2005057215A1 Membrane-based lateral flow assay devices that utilize phosphorescent detection
06/23/2005WO2005057214A1 Method for extending the dynamic detection range of assay devices
06/23/2005WO2005057213A1 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
06/23/2005WO2005057212A2 Device for sensing contaminants
06/23/2005WO2005057211A1 Method of rating hair damage with use of oxidized protein occurring in hair as indicator
06/23/2005WO2005057210A1 Urine component detecting system and detector
06/23/2005WO2005057209A2 Sample age monitoring devices and methods
06/23/2005WO2005057208A1 Methods of identifying peptides and proteins
06/23/2005WO2005057207A1 Trityl derivatives for enhancing mass spectrometry
06/23/2005WO2005057202A1 Method and device for electrically testing fuels and combustibles by generating a plasma
06/23/2005WO2005057199A1 Multiparameter system for environmental monitoring
06/23/2005WO2005057198A1 Use of siloxane-based polymers or composites in chemical sensors for detecting nitrate compounds
06/23/2005WO2005057192A1 Sensitive system for detecting chemical and/or physical state changes inside packaged media
06/23/2005WO2005057177A1 Systems and methods for detecting contaminants
06/23/2005WO2005057176A2 Method for identification of enzymes
06/23/2005WO2005057174A2 Method and apparatus for low blood glucose level detection
06/23/2005WO2005057172A2 Identification, isolation and elimination of cancer stem cells
06/23/2005WO2005057171A2 Protein-protein interaction antagonist screening libraries based upon 1,4-disubstituted naphthalenes and related scaffolds
06/23/2005WO2005057169A2 Homogeneous competition assays
06/23/2005WO2005057167A2 Retaining clip for reagent test slides
06/23/2005WO2005057166A2 Detection of conformationally altered proteins and prions
06/23/2005WO2005057160A2 Paper producing device
06/23/2005WO2005057153A1 Device for a torque or shear force transmitter for the determination of fibre concentration or viscosity in pulp suspensions and method for resetting of the transmitter shaft in a torque or shear force transmitter
06/23/2005WO2005057142A1 A method and flow meter for determining the flow rates of a multiphase fluid
06/23/2005WO2005057059A1 Seal for measuring device
06/23/2005WO2005056837A2 Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
06/23/2005WO2005056824A1 Method of detecting sulfate-conjugated bile acid and test paper and biosensor to be used therein
06/23/2005WO2005056823A1 Method of measuring saccharified amine
06/23/2005WO2005056822A1 Method of judging clinical malignancy of fals
06/23/2005WO2005056817A2 Method for recovering microorganisms from a sample
06/23/2005WO2005056816A1 Charcoal stabilization of phenyl phosphates
06/23/2005WO2005056814A2 Methods and systems for analyzing and determining ligand-residue interaction
06/23/2005WO2005056807A2 Bovine adeno-associated viral (baav) vector and uses thereof
06/23/2005WO2005056789A1 Cellular membrane composition and method of preparing the same
06/23/2005WO2005056781A1 Use of proteins and peptides coded by the genome of a novel strain of sars-associated coronavirus
06/23/2005WO2005056778A1 Method of regulating the differentiation of hematopoietic stem cells or proliferating the same
06/23/2005WO2005056761A2 REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi
06/23/2005WO2005056759A2 Methods of generating variant proteins with increased host string content and compositions thereof
06/23/2005WO2005056751A2 Apparatus and method for concentrating stem cell
06/23/2005WO2005056689A2 Cyanine dye compounds
06/23/2005WO2005056687A2 Methine-substituted cyanine dye compounds
06/23/2005WO2005056613A2 Site selectively tagged and templated molecularly imprinted polymers for sensor applications
06/23/2005WO2005056601A2 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse?
06/23/2005WO2005056599A2 Antibodies that specifically bind pms2
06/23/2005WO2005056597A1 IMMUNOGLOBULIN Fc RECEPTOR PROTEIN
06/23/2005WO2005056590A1 Novel interaction between proteins, therapeutic agent for disuse atrophy utilizing the novel interaction, and method relating to disuse atrophy
06/23/2005WO2005056584A2 Novel strain of sars-associated coronavirus and applications thereof
06/23/2005WO2005056579A1 Interleukin 6 crystals having novel crystalline structure
06/23/2005WO2005056576A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof
06/23/2005WO2005056569A2 Beta integrin gene and protein
06/23/2005WO2005056523A2 Methodology for preparing combinatorial libraries based upon a bicyclic scaffold
06/23/2005WO2005056146A2 Method of detection, separation and identification for expressed trace protein/peptide
06/23/2005WO2005056145A2 Biological chip and use thereof
06/23/2005WO2005056055A2 METHODS OF PROTECTING AGAINST RADIATION USING INDUCERS OF NF-κB
06/23/2005WO2005056049A1 Methods and compounds for modulating triglyceride and vldl secretion
06/23/2005WO2005056043A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/23/2005WO2005056042A2 Methods of protecting against radiation using flagellin
06/23/2005WO2005056041A2 METHODS OF INHIBITING APOPTOSIS USING LATENT TGFβ
06/23/2005WO2005055936A2 Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
06/23/2005WO2005055925A2 14-3-3 zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types
06/23/2005WO2005055813A2 Interaction of nmda receptor with the protein tyrosine phosphatase step in psychotic disorders
06/23/2005WO2005055812A2 Serum biomarkers for chagas disease
06/23/2005WO2005055810A2 Risk markers for cardiovascular disease
06/23/2005WO2005055808A2 Compositions and methods to diagnose and treat lung cancer
06/23/2005WO2005055728A1 Method for determining the quality of a slaughtered animal carcass and quantities therein
06/23/2005WO2005055706A1 DISEASE MODEL ANIMAL EXPRESSING MEGSIN/RAGE/iNOS AND METHOD OF EVALUATING COMPOUND WITH THE USE OF THE ANIMAL
06/23/2005WO2005049787A9 Compositions and methods for in vitro sorting of molecular and cellular libraries
06/23/2005WO2005047891A3 Method, apparatus and system for forecasting strength of cementitious material
06/23/2005WO2005040829A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 17 (gpr17)
06/23/2005WO2005040827A3 Diagnostics and therapeutics for diseases associated with organic cationic transporter-like 4 (orctl4) (orctl4)
06/23/2005WO2005040800B1 Method for producing and using a new protein array, said protein array and the applications thereof
06/23/2005WO2005040401A3 Diagnostics and therapeutics for diseases associated with mosaic serine protease (msp)
06/23/2005WO2005039724A3 Reactive polyurethane-based polamers
06/23/2005WO2005037312A3 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques
06/23/2005WO2005037059A3 Multi-marker screening protocol for fetal abnormalities
06/23/2005WO2005031367A3 High throughput automated seed analysis system